肠道病毒A71 2A-S125A作为减弱的候选疫苗,表明在开发肠道病毒疫苗的普遍方法
Peng Zhang1, Wenjia Zou1, Rui Xiong1
1Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Journal of medical virology
|July 31, 2024
概括
一个新的肠道病毒疫苗候选人,EV-A71 2A-125A突变,显示出有希望. 这种减弱的病毒提供了对肠道病毒A71菌株的保护,这表明了更广泛的肠道病毒疫苗开发的潜力.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 肠道病毒是重要的人类病原体,具有众多的血清型,使疫苗开发复杂化.
- 脊髓灰质炎疫苗的成功凸显了对有效肠道病毒疫苗的需求.
- 新兴的肠道病毒传染病突显了新的疫苗策略的紧迫性.
研究的目的:
- 评估肠道病毒A71 (EV-A71) 2A-125A突变体作为候选疫苗的潜力.
- 在小鼠模型中评估EV-A71 2A-125A突变体的安全性,免疫性和保护功效.
主要方法:
- 在EV-A71 2A-125A突变被给予hSCARB2-KI小鼠.
- 随后,小鼠接受了EV-A71野生型菌株的挑战.
- 分析了病毒载量,病理变化,免疫反应和细胞因子表达.
主要成果:
- EV-A71 2A-125A突变体表现出衰减,导致轻度症状和较低的病毒载荷.
- 突变者诱导了对EV-A71菌株的长期交叉中和抗体.
- 暴露前显著保护小鼠免受野生型EV-A71挑战,减少炎症和预防神经损伤.
结论:
- 这种EV-A71 2A-125A突变是一种安全有效的疫苗候选.
- 它引起了强大的免疫反应,并对EV-A71感染提供了显著的保护.
- 这种减弱突变物有可能成为开发肠道病毒疫苗的全球解决方案.
相关概念视频
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


